No Data
Jiangsu Aoyang Health Industryltd's (SZSE:002172) Solid Earnings Are Supported By Other Strong Factors
Australian Ocean Health: Report for the third quarter of 2024
Jiangsu Aoyang Health Industry (002172.SZ) released its performance for the first three quarters, with a net income of 38.6781 million yuan, a year-on-year decrease of 2.39%.
Jiangsu Aoyang Health Industry (002172.SZ) released the third quarter report for 2024. In the first three quarters, the company achieved revenue...
Jiangsu Aoyang Health Industry (002172.SZ): The net income for the first three quarters was 38.6781 million yuan, a year-on-year decrease of 2.39%.
Gelonghui October 30th | Jiangsu Aoyang Health Industry (002172.SZ) released the third quarter report for 2024, with the company achieving revenue of 1.501 billion yuan in the first three quarters, a decrease of 7.54% year-on-year; net income attributable to shareholders of the listed company was 38.6781 million yuan, a decrease of 2.39% year-on-year; net income attributable to shareholders of the listed company excluding non-recurring gains and losses was 35.8295 million yuan, an increase of 18.21% year-on-year; basic earnings per share was 0.0505 yuan.
Jiangsu Aoyang Health Industry Co.ltd.'s (SZSE:002172) Market Cap Surged CN¥368m Last Week, Retail Investors Who Have a Lot Riding on the Company Were Rewarded
Australian Ocean Health: Semi-Annual Report 2024
Investors Don't See Light At End Of Jiangsu Aoyang Health Industry Co.ltd.'s (SZSE:002172) Tunnel
